Ostatní
Návod 
GE HealthCare Technologies Inc.
GEHC
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
33.3B
Obrat
20B
Zisk
2B
Aktiva
36B
Dluh
11B
ROE
0%
ROA
0%
PE
19
PS
2
Cena 1R
58-95
⌀ Cena
74.67
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
12-02-2026
Poslední dividenda
02-04-2026
Profil
Společnost GE HealthCare Technologies Inc. se zabývá vývojem, výrobou a uváděním na trh produktů, služeb a doplňkových digitálních řešení používaných při diagnostice, léčbě a monitorování pacientů ve Spojených státech, Kanadě, Evropě, na Blízkém východě, v Africe, Číně, na Tchaj-wanu, v Mongolsku, Hongkongu a v mezinárodním měřítku. Společnost působí ve čtyřech segmentech: zobrazování, ultrazvuk, řešení péče o pacienty a farmaceutická diagnostika. Segment zobrazování nabízí molekulární zobrazování, počítačovou tomografii (CT), zobrazování pomocí magnetické rezonance (MR), obrazově řízenou terapii a rentgenové systémy, stejně jako ženské zdravotnické produkty. Segment Ultrazvuku poskytuje screening, diagnostiku, léčbu a sledování určitých onemocnění prostřednictvím radiologie a primární péče, zdraví žen, kardiovaskulární a místo péče a ruční ultrazvukové řešení, stejně jako chirurgické vizualizace a naváděcí produkty. Segment řešení pro péči o pacienty, který se zabývá poskytováním zdravotnických prostředků, spotřebních produktů, služeb a digitálních řešení prostřednictvím monitorování pacienta, anestezie a respirační péče, diagnostické kardiologie a výrobků pro péči o dítě matky. Farmaceutická diagnostika dodává diagnostické prostředky, včetně CT, angiografie a rentgenového záření, MR, jednofotonové emisní výpočetní tomografie, pozitronové emisní tomografie a ultrazvuku pro radiologii a jadernou medicínu. Segment také poskytuje farmaceutická kontrastní média, která se pacientovi podávají před určitým diagnostickým skenováním, aby se zvýšila viditelnost tkání nebo struktur během zobrazovacích vyšetření, a molekulární zobrazovací látky, nebo radiofarmaka, což jsou molekulární stopovací látky označené radioizotopy, které se pacientovi podávají před diagnostickým zobrazovacím skenováním. Společnost byla založena v roce 2022 a sídlí v Chicagu ve státě Illinois.
Sektor
Healthcare
Odvětví
Medical - Healthcare Information Services
Počet zaměstnanců
53000
Založení
2022-12-15
Podobné společnosti
$ 243.67
- $ 8.38
$ 211.92
+ $ 1.46
$ 202.89
- $ 0.78
$ 186.60
- $ 3.10
$ 74.07
+ $ 0.10
$ 248.57
- $ 2.92
$ 146.16
- $ 0.58
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 19.60 | 20.63 | 19.67 | 19.55 | 18.34 | 17.59 | 17.16 | 16.63 | |
| Cost of Revenues | 11.08 | 12.38 | 11.47 | 11.63 | 11.16 | 10.41 | 10.40 | 10.09 | |
| Gross Profit | 8.53 | 8.25 | 8.21 | 7.92 | 7.18 | 7.17 | 6.77 | 6.55 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 4.67 | 5.14 | 5.01 | 4.78 | 5.32 | 4.86 | 4.84 | 4.65 | 5.21 | 4.82 | |
| Cost of Revenues | 2.13 | 3.15 | 3.02 | 2.77 | 3.04 | 2.84 | 2.84 | 2.75 | 3.05 | 2.89 | |
| Gross Profit | 2.54 | 1.99 | 1.99 | 2.01 | 2.28 | 2.03 | 2.00 | 1.90 | 2.16 | 1.94 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 1.21 | 1.03 | 0.82 | 0.81 | 0.83 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 4.28 | 3.63 | 3.56 | 3.24 | 3.59 | |
| Depreciation & Amortization | 0.98 | 0.58 | 0.58 | 0.61 | 0.70 | 0.75 | 0.69 | 0.71 | |
| Total Operating Expenses | 5.93 | 5.49 | 5.58 | 5.49 | 4.66 | 4.38 | 4.05 | 4.42 | |
| Operating Income | 2.60 | 2.76 | 2.63 | 2.44 | 2.52 | 2.80 | 2.72 | 2.12 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 | 0.32 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.15 | 1.00 | ||
| Depreciation & Amortization | 0.55 | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 | 0.15 | 0.15 | 0.14 | 0.15 | ||
| Total Operating Expenses | 1.88 | 1.34 | 1.33 | 1.38 | 1.47 | 1.35 | 1.39 | 1.36 | 1.47 | 1.32 | ||
| Operating Income | 0.66 | 0.65 | 0.65 | 0.63 | 0.80 | 0.68 | 0.61 | 0.54 | 0.69 | 0.62 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.03 | 0.05 | 0.04 | |
| Interest Expense | 0.45 | 0.45 | 0.51 | 0.54 | 0.08 | 0.04 | 0.07 | 0.09 | |
| Other Expense | -0.45 | 0.01 | -0.04 | -0.07 | -0.01 | 0.08 | -0.01 | -0.03 | |
| IBT | 2.15 | 2.77 | 2.58 | 2.36 | 2.51 | 2.88 | 2.71 | 2.09 | |
| Income Tax Expense | 0.45 | 0.61 | 0.53 | 0.74 | 0.56 | 0.60 | 0.65 | 0.41 | |
| Net Income | 1.68 | 2.08 | 1.99 | 1.57 | 1.92 | 2.25 | 2.06 | 1.52 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | -0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | ||
| Interest Expense | 0.10 | 0.12 | 0.11 | 0.11 | 0.11 | 0.13 | 0.13 | 0.14 | 0.13 | 0.14 | ||
| Other Expense | -0.46 | -0.01 | -0.04 | 0.06 | 0.03 | -0.02 | -0.03 | -0.03 | -0.08 | 0.02 | ||
| IBT | 0.20 | 0.64 | 0.61 | 0.69 | 0.83 | 0.66 | 0.58 | 0.51 | 0.61 | 0.64 | ||
| Income Tax Expense | 0.05 | 0.18 | 0.11 | 0.10 | 0.10 | 0.17 | 0.14 | 0.12 | 0.19 | 0.25 | ||
| Net Income | 0.18 | 0.45 | 0.49 | 0.56 | 0.72 | 0.47 | 0.43 | 0.37 | 0.40 | 0.38 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $3.04 | $0.04 | $4.94 | $4.53 | $3.35 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $3.02 | $0.04 | $4.94 | $4.53 | $3.35 | |
| Shares Outstanding | 0.46 | 0.46 | 0.46 | 0.46 | 0.45 | 0.45 | 0.45 | 0.45 | |
| Diluted Shares Outstanding | 0.46 | 0.46 | 0.46 | 0.46 | 0.45 | 0.45 | 0.45 | 0.45 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.89 | $0.82 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.88 | $0.82 | ||
| Shares Outstanding | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | ||
| Diluted Shares Outstanding | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 2.01 | 2.89 | 2.49 | 1.45 | 0.55 | 0.99 | |
| Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 2.01 | 2.89 | 2.49 | 1.45 | 0.55 | 0.99 | |
| Accounts Receivable | 4.13 | 4.38 | 4.25 | 4.30 | 3.79 | 2.66 | |
| Inventory | 2.02 | 1.94 | 1.96 | 2.16 | 1.95 | 1.59 | |
| Other Current Assets | 0.28 | 0.31 | 0.70 | 0.42 | 0.09 | 0.10 | |
| Total Current Assets | 8.44 | 9.52 | 9.41 | 8.32 | 7.00 | 5.90 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 4.01 | 3.76 | 2.47 | 2.89 | 3.57 | 2.01 | 2.56 | 2.49 | 2.42 | 1.94 | |
| Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 4.01 | 3.76 | 2.47 | 2.89 | 3.57 | 2.01 | 2.56 | 2.49 | 2.42 | 1.94 | |
| Accounts Receivable | 4.68 | 4.48 | 4.35 | 4.38 | 4.28 | 4.13 | 4.09 | 4.32 | 4.15 | 4.14 | |
| Inventory | 2.30 | 2.28 | 2.16 | 1.94 | 2.12 | 2.02 | 1.99 | 1.96 | 2.13 | 2.26 | |
| Other Current Assets | 0.90 | 0.39 | 0.40 | 0.31 | 0.31 | 0.28 | 0.35 | 1.12 | 0.78 | 0.90 | |
| Total Current Assets | 11.89 | 10.92 | 9.38 | 9.52 | 10.28 | 8.44 | 8.99 | 9.41 | 9.47 | 9.24 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 2.46 | 2.55 | 2.50 | 2.31 | 2.24 | 2.20 | |
| Goodwill | 13.12 | 13.14 | 12.94 | 12.81 | 12.89 | 11.87 | |
| Intangible Assets | 1.20 | 1.08 | 1.25 | 1.52 | 1.85 | 1.60 | |
| Long-Term Investments | 0.75 | 0.80 | 0.36 | 0.32 | 0.34 | 0.34 | |
| Other Long-Term Assets | 1.53 | 1.53 | 1.52 | 0.70 | 0.29 | 0.38 | |
| Total Long-Term Assets | 23.41 | 23.57 | 23.04 | 19.22 | 19.31 | 18.33 | |
| Total Assets | 31.85 | 33.09 | 32.45 | 27.54 | 26.31 | 24.23 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.01 | 2.96 | 2.85 | 2.55 | 2.54 | 2.46 | 2.45 | 2.50 | 2.36 | 2.36 | |
| Goodwill | 13.44 | 13.42 | 13.37 | 13.14 | 13.14 | 13.12 | 12.93 | 12.94 | 12.91 | 12.93 | |
| Intangible Assets | 1.16 | 1.22 | 1.24 | 1.08 | 1.13 | 1.20 | 1.17 | 1.25 | 1.33 | 1.42 | |
| Long-Term Investments | 0.30 | 0.72 | 0.69 | 0.80 | 0.80 | 0.75 | 0.74 | 0.36 | 0.40 | 0.41 | |
| Other Long-Term Assets | 1.85 | 1.75 | 1.60 | 1.53 | 1.66 | 1.53 | 1.52 | 1.52 | 1.63 | 1.61 | |
| Total Long-Term Assets | 24.23 | 24.59 | 24.21 | 23.57 | 23.58 | 23.41 | 23.22 | 23.04 | 22.91 | 23.07 | |
| Total Assets | 36.13 | 35.50 | 33.59 | 33.09 | 33.86 | 31.85 | 32.21 | 32.45 | 32.38 | 32.31 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.82 | 3.02 | 2.95 | 2.94 | 2.54 | 2.16 | |
| Short-Term Debt | 1.12 | 1.62 | 1.12 | 0.02 | 0.11 | 0.13 | |
| Other Current Liabilities | 2.50 | 2.69 | 3.00 | 2.34 | 2.25 | 2.42 | |
| Current Liabilities | 8.32 | 9.55 | 8.98 | 7.19 | 6.76 | 6.52 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.99 | 2.98 | 3.15 | 3.02 | 2.91 | 2.82 | 2.93 | 2.95 | 2.77 | 2.84 | |
| Short-Term Debt | 2.14 | 2.26 | 2.12 | 1.62 | 1.12 | 1.12 | 1.12 | 1.12 | 0.01 | 0.01 | |
| Other Current Liabilities | 2.72 | 2.35 | 2.81 | 2.69 | 2.56 | 2.30 | 2.67 | 3.00 | 2.86 | 2.74 | |
| Current Liabilities | 10.07 | 9.75 | 9.97 | 9.55 | 8.67 | 8.32 | 8.86 | 8.98 | 7.57 | 7.58 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Long-Term Debt | 8.23 | 7.76 | 8.75 | 8.23 | 0.33 | 0.34 | |
| Capital Leases | 0.31 | 0.43 | 0.42 | 0.39 | 0.40 | 0.43 | |
| Def. Tax Liability | 0.06 | 0.06 | 0.07 | 0.37 | 0.39 | 0.46 | |
| Total Liabilities | 23.86 | 24.44 | 25.14 | 18.18 | 9.63 | 9.48 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 8.61 | 8.58 | 7.06 | 7.76 | 9.61 | 8.54 | 8.55 | 8.75 | 10.62 | 10.23 | |
| Capital Leases | 0.46 | 0.44 | 0.43 | 0.43 | 0.42 | 0.31 | 0.41 | 0.42 | 0.37 | 0.37 | |
| Def. Tax Liability | 0.17 | 0.17 | 0.16 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 | |
| Total Liabilities | 25.91 | 25.55 | 24.17 | 24.44 | 25.35 | 23.86 | 24.61 | 25.14 | 25.24 | 24.99 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Common Stock | 0.01 | 0.01 | 0.01 | 11.24 | 17.69 | 15.57 | |
| Retained Earnings | 2.10 | 3.26 | 1.33 | 0.00 | 0.00 | 0.00 | |
| Comprehensive Income | -0.85 | -1.38 | -0.69 | -1.88 | -1.04 | -0.84 | |
| Total Common Equity | 7.80 | 8.45 | 7.13 | 9.36 | 16.66 | 14.73 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Retained Earnings | 4.71 | 4.30 | 3.81 | 3.26 | 2.56 | 2.10 | 1.69 | 1.33 | 0.94 | 0.58 | |
| Comprehensive Income | -1.16 | -1.09 | -1.20 | -1.38 | -0.77 | -0.85 | -0.79 | -0.69 | -0.28 | 0.07 | |
| Total Common Equity | 9.99 | 9.71 | 9.19 | 8.45 | 8.32 | 7.80 | 7.41 | 7.13 | 7.13 | 7.10 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Total Debt | 9.66 | 9.38 | 9.86 | 8.25 | 0.44 | 0.47 | |
| Book Value | 8.00 | 8.65 | 7.31 | 9.36 | 16.68 | 14.75 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.23 | 0.24 | 0.23 | 0.21 | 0.20 | 0.19 | 0.19 | 0.18 | 0.01 | 0.22 | |
| Book Value | 9.99 | 9.71 | 9.19 | 8.45 | 8.32 | 7.80 | 7.41 | 7.13 | 7.13 | 7.10 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.62 | 2.15 | 2.05 | 1.57 | 1.95 | 2.28 | 2.06 | 1.68 | |
| Depreciation & Amortization | 0.60 | 0.58 | 0.58 | 0.61 | 0.63 | 0.63 | 0.63 | 0.66 | |
| Stock-Based Compensation | 0.13 | 0.13 | 0.13 | 0.11 | 0.00 | 0.00 | -0.93 | 0.15 | |
| Change Working Capital | -0.28 | -0.36 | -0.06 | -0.13 | -0.26 | -1.37 | -0.05 | -0.39 | |
| Change In Accounts Receivable | -0.04 | -0.22 | -0.15 | -0.19 | -0.23 | -1.34 | -0.22 | -0.27 | |
| Change In Accounts Payable | -0.01 | 0.09 | 0.13 | -0.01 | 0.48 | 0.26 | -0.11 | 0.00 | |
| Change In Inventories | 0.17 | -0.14 | -0.08 | 0.11 | -0.40 | -0.44 | 0.10 | -0.17 | |
| Other Non-cash Items | 0.04 | -0.52 | -1.28 | -0.80 | -0.78 | -0.52 | -0.67 | -0.53 | |
| Cash from Operations | 2.00 | 0.00 | 0.00 | 2.10 | 2.11 | 1.61 | 1.69 | 1.99 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.59 | 0.46 | 0.50 | 0.59 | 0.74 | 0.49 | 0.44 | 0.39 | 0.42 | 0.39 | |
| Depreciation & Amortization | 0.00 | 0.15 | 0.15 | 0.14 | 0.14 | 0.14 | 0.15 | 0.15 | 0.14 | 0.15 | |
| Stock-Based Compensation | 0.00 | 0.04 | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 | 0.03 | |
| Change Working Capital | 0.26 | -0.09 | -0.25 | -0.14 | 0.22 | 0.09 | -0.48 | 0.15 | 0.21 | -0.15 | |
| Change In Accounts Receivable | -0.21 | -0.25 | 0.00 | 0.13 | -0.22 | -0.06 | -0.06 | 0.20 | -0.10 | -0.05 | |
| Change In Accounts Payable | 0.21 | -0.01 | -0.26 | 0.15 | 0.12 | 0.10 | -0.13 | 0.08 | 0.08 | -0.05 | |
| Change In Inventories | 0.08 | -0.03 | -0.03 | -0.15 | 0.08 | -0.04 | -0.06 | -0.06 | 0.20 | 0.09 | |
| Other Non-cash Items | -0.02 | -0.15 | -0.45 | -0.46 | -0.31 | -0.17 | -0.40 | -0.43 | 0.05 | -0.02 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.05 | 0.65 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.38 | -0.48 | -0.40 | -0.39 | -0.31 | -0.25 | -0.26 | -0.33 | |
| Acquisitions | -0.11 | 0.00 | -0.31 | -0.15 | 0.00 | -1.48 | -0.08 | 0.00 | |
| Investments | 0.00 | -0.12 | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | -0.10 | 0.00 | 0.00 | -0.02 | -0.09 | -0.03 | 20.32 | 0.01 | |
| Cash from Investing | -0.75 | 0.00 | 0.00 | -0.56 | -0.40 | -1.76 | 19.99 | -0.33 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.13 | -0.11 | -0.09 | -0.15 | -0.10 | -0.09 | -0.06 | -0.15 | -0.09 | -0.08 | |
| Acquisitions | -0.10 | 0.00 | -0.01 | -0.27 | -0.05 | 0.00 | -0.26 | 0.00 | 0.15 | 0.00 | |
| Investments | -0.04 | -0.05 | -0.01 | -0.02 | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | |
| Sales of Investment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | -0.04 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | -0.12 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1.00 | 0.00 | 0.00 | 1.14 | 0.00 | -0.02 | -0.02 | -0.06 | |
| Debt Issued | 0.43 | 9.38 | -0.49 | 2.75 | 7.82 | -0.01 | 0.49 | 0.06 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | 0.00 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -0.06 | 0.00 | 0.00 | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -0.08 | 0.00 | 0.00 | -1.58 | -0.82 | -0.25 | -21.52 | -1.51 | |
| Cash from Financing | -1.13 | 0.00 | 0.00 | -0.48 | -0.82 | -0.26 | -21.54 | -1.57 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.86 | 0.02 | |
| Debt Issued | 10.74 | -0.10 | 1.66 | -0.19 | -1.36 | 1.07 | -0.01 | -0.20 | 0.46 | 0.04 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | -0.03 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.90 | -0.02 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.07 | 1.62 | 0.39 | 1.06 | 0.89 | -0.45 | 0.14 | 0.04 | |
| Closing Cash Balance | 2.01 | 4.52 | 2.89 | 2.51 | 1.45 | 0.56 | 1.01 | 0.87 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.49 | 0.26 | 1.29 | -0.42 | -0.68 | 1.55 | -0.55 | 0.06 | 0.09 | 0.48 | |
| Closing Cash Balance | 4.51 | 4.03 | 3.77 | 2.48 | 2.89 | 3.57 | 2.02 | 2.57 | 2.51 | 2.42 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.62 | 1.51 | 1.55 | 1.71 | 1.80 | 1.36 | 1.43 | 1.66 | |
| Real Free Cash Flow | 1.49 | 1.38 | 1.43 | 1.60 | 1.80 | 1.36 | 2.36 | 1.51 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.92 | 0.48 | 0.01 | 0.10 | 0.81 | 0.65 | -0.18 | 0.27 | 0.96 | 0.57 | |
| Real Free Cash Flow | 0.92 | 0.45 | -0.03 | 0.08 | 0.78 | 0.63 | -0.22 | 0.24 | 0.92 | 0.54 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 19.1 | 19 | 120.8 |
| P/S | 1.6 | 1.8 | 9.7 |
| P/B | 3.1 | 4.1 | 738.2 |
| P/FCF | 22.7 | 28.7 | 111.3 |
| Market cap | $33.3 | $36.3 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 20 % | 0 % |
| Debt to Income | 639.5 % | 361.8 % | 0 % |
| Debt to Free cash flow | 760.9 % | 56.1 % | 0 % |
| Interest expense percentage | 17.3 % | 13.2 % | 18.1 % |
| Current ratio | 1.2 | 0.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 16.8 % | 17.1 % | 0 % |
| ROA | 4.7 % | 4.6 % | 0 % |
| CapEx to Revenue | 2.5 % | 2 % | 2.4 % |
| RaD to Revenue | 0 % | 5.3 % | 0 % |
| ROEM | 369,811.3 | 69036.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 43.5 % | 40.6 % | 89.7 % |
| Operating margin | 13.3 % | 13.3 % | 37.4 % |
| Net margin | 8.6 % | 9.9 % | 37.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.1 % | 0 % |
| Dividend payout percentage | 0 % | 1.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 460.3 mil | 455.5 mil |
| Employee count | 53.0 tis | 51.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
